Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04654182
Other study ID # #2007591-102
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date November 30, 2020
Est. completion date December 24, 2020

Study information

Verified date February 2021
Source Molnlycke Health Care AB
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the residual antimicrobial effectiveness of one test product when tested using a modification of the methodology of the standardized ASTM E115-11 (2017)


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date December 24, 2020
Est. primary completion date December 24, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Subjects may be of either sex, between the ages of 18 and 65 years, and of any race. - Subjects must be able to read and understand English. - Subjects must possess both hands and all ten digits. - Subjects must have an average baseline population of at least 1.0 x 105 colony forming units (CFU) per hand. - Subjects must have no active skin rashes, dermatoses, hangnails, or breaks in the skin of the hands or forearms. Subjects must also have no inflammatory skin conditions, such as dermatitis, eczema, or psoriasis, anywhere on the body. - Subjects must be in good general health and have no medical diagnosis of a physical condition, such as a current or recent severe illness, a heart murmur, mitral valve prolapse with heart murmur, congenital heart disease, an organ transplant, medicated or uncontrolled diabetes, hepatitis B, hepatitis C, an immunocompromised condition such as AIDS (or HIV positive), lupus, fibromyalgia, ulcerative colitis, Crohn's disease, asthma, heart disease, hypertension, or medicated multiple sclerosis. - Subjects must have read and signed the Informed Consent Form, List of Restricted Products, and Allowed and Restricted Products For Hand Cleaning During Coronavirus Disease 2019 (COVID-19) Pandemic prior to participating in the study, all located in the separate Informed Consent documents. Subjects must also have a current Authorization to Use and Disclose Protected Health Information Form on file at the testing facility. Exclusion Criteria: - Have participated in a clinical study in the past 7 days or be currently participating in another clinical study. - Wash the hands or applying lotion within the 2-hour period prior to baseline sampling or testing. - Be experiencing any signs/symptoms of respiratory illness, including cough, fever (body temperature of = 100.0 °F) or chills, shortness of breath or difficulty breathing, persistent pain or pressure in the chest, confusion or inability to respond to external stimuli, bluish lips/face, loss of taste/smell, sore throat, headache, nasal discharge ("runny nose"), frequent sneezing, or general fatigue / body aches. - Have a current diagnosis of active Coronavirus Disease 2019 (COVID-19) or have been in close contact within the last 2 weeks of anyone who has been diagnosed as having contracted COVID-19. - Have been regularly smoking or vaping over the past 2 years. - Have limited mobility or dexterity that would hamper their ability to perform the study as directed. - Have known allergies or sensitivities to latex (rubber), alcohols, sunscreens, deodorants, laundry detergents, topically applied fragrances, cleansers, soaps, lotions, or to common antibacterial agents, particularly chlorohexidine gluconate. - Have experienced hives (raised welts) as a reaction to anything that contacted the skin with the exception of plants known to cause reactions for most humans (e.g., poison oak or poison ivy). - Have a history of anaphylactic shock, anaphylactoid reaction, or anaphylactoid shock. - Have a known hypersensitivity to the test product or any of its components, especially in those with a history of possible chlorhexidine-related allergic reactions. - Contact the brain, cerebral membrane, middle ear and eyes with the test product and such contact must be avoided. - Be receiving any antibiotic medications during the 7-day pre-test period through completion of the study. - Be receiving any steroids (including steroid medications used to treat asthma) other than for contraception, hormone therapy, or menopausal purposes during the 7-day pre-test period through completion of the study. - Have any type of port (or portacath) or Peripherally Inserted Central Catheter (PICC). - Be nursing a child. - Be pregnant, plan to become pregnant or impregnate a sexual partner within the pre-test and test periods of the study. - Have any medical condition or use any medications that, in the opinion of the Principal Investigator, or Consulting Physician(s) should preclude participation.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Chlorhexidine Gluconate
Product used in accordance with manufacturers Hand Hygiene instructions

Locations

Country Name City State
United States Bioscience Laboratories, Inc Bozeman Montana

Sponsors (2)

Lead Sponsor Collaborator
Molnlycke Health Care AB BIOSCIENCE LABORATORIES, INC.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bacterial counts Average Log reduction in counts at 6 hours
Primary Bacterial Counts Average Log reduction in counts at 12 hours
See also
  Status Clinical Trial Phase
Completed NCT04267952 - Hand Hygiene Intervention Program on Primary School Students' Health Outcomes and Absenteeism in School N/A
Completed NCT04102488 - Simplifying the World Health Organization (WHO) Protocol for Hand Hygiene: Three Steps and 15 Seconds N/A
Completed NCT03948672 - CleanHands Sensor Based System to Improve Hand Hygiene and Reduce Infection N/A
Completed NCT02223455 - Building an Optimal Hand Hygiene Bundle N/A
Completed NCT02396836 - Randomised Controlled Trial (RCT) of 6 Versus 3 Steps for Hand Hygiene N/A
Completed NCT04830761 - Behavior Change in Context to Contain the Spread of COVID-19 N/A
Completed NCT03445676 - Effectiveness of an Alcohol-based Hand Rub to "Clean" Gloved Hands N/A
Enrolling by invitation NCT05395988 - Hand Hygiene of Kindergarten Children N/A
Completed NCT05872581 - Education Program of Hand Hygiene for Nursing Students N/A
Completed NCT04053257 - Effect of Video Camera Monitoring Feedback on Hand Hygiene Compliance and Infections in NICU N/A
Completed NCT03588221 - Simplifying the World Health Organization (WHO) Protocol for Hand Hygiene N/A
Completed NCT03204175 - Fit Plus: Assessing the Impact of a School-based Intervention on Toilet Quality N/A
Not yet recruiting NCT06211660 - An Edge AI-based AR System for Hand Hygiene Training in Undergraduates of Health Related Disciplines N/A
Completed NCT05848596 - Handwashing Knowledge and Practice of Palliative Care N/A
Completed NCT03165799 - Mindfulness to the Clinical Setting: The Mind Hand Connection Study N/A
Recruiting NCT05964478 - Hands4Health: A Multi-component Intervention on Hand Hygiene & Well-being in Schools in Nigeria & Palestine (H4H) N/A
Not yet recruiting NCT02645110 - Evaluation of Effectiveness and Mildness of Whole-natural Hand-wash Formulations N/A
Completed NCT04773288 - Handy Hygiene of Children: Understanding the Effect of Live Feedback on Handwashing Behavior N/A
Completed NCT03119389 - Direct Gloving Strategy: A Cluster-randomized Trial N/A
Not yet recruiting NCT04187040 - SIMPLIFY the Hand Hygiene Procedure - Three Steps Versus Six Steps for Performing Hand Hygiene (SIMPLIFY Study) N/A